Current systemic therapies for psoriasis: where are we now?
Authors:
- Dalia RizkDRDalia Rizk
- Tanya KormeiliTKTanya Kormeili
- Rickie PatnaikRPRickie Patnaik
- Nicholas J LoweNLNicholas J Lowe
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (2) , 66-77
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Treatment of psoriasis. Part 2. Systemic therapiesJournal of the American Academy of Dermatology, 2001
- Cyclosporine as maintenance therapy in patients with severe psoriasisJournal of the American Academy of Dermatology, 1997
- Proceedings of the Psoriasis Combination and Rotation Therapy ConferenceJournal of the American Academy of Dermatology, 1996
- 6-Thioguanine treatment of psoriasis: Experience in 81 patientsJournal of the American Academy of Dermatology, 1994
- Acitretin plus UVB therapy for psoriasisJournal of the American Academy of Dermatology, 1991
- Immunity during cyclosporine therapyJournal of the American Academy of Dermatology, 1990
- Sulfasalazine: A potential psoriasis therapy?Journal of the American Academy of Dermatology, 1989
- Systemic retinoid therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- Efficacy of mycophenolic acid for the treatment of psoriasisJournal of the American Academy of Dermatology, 1979